New York, April 10 – JPMorgan Chase Financial Co. LLC priced $2.37 million of autocallable contingent interest notes due March 26, 2026 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
Investors will receive a coupon of 13.1%, paid quarterly, if the ETF closes at or above its 80% trigger level on the related valuation date, plus any previously unpaid coupons.
The securities will be called automatically at par if the ETF closes at or above its initial level on any quarterly review date starting March 24, 2025.
At maturity, the payout will be par unless the ETF finishes below its 80% trigger level, in which case investors will be fully exposed to the decline of the ETF.
The notes are guaranteed by JPMorgan Chase & Co.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Autocallable contingent interest notes
|
| Underlying ETF: | SPDR S&P Biotech ETF (Ticker: XBI)
|
| Amount: | $2.37 million
|
| Maturity: | March 26, 2026
|
| Coupon: | 13.1%, paid quarterly, if the ETF closes at or above its 80% trigger level on the related valuation date, plus any previously unpaid coupons
|
| Price: | Par
|
| Payout at maturity: | Par unless the ETF finishes below its trigger level, in which case investors will be fully exposed to the decline in the ETF
|
| Call: | Automatically at par if the ETF closes at or above its initial level on any quarterly review date starting March 24, 2025
|
| Initial level: | $93.56
|
| Trigger level: | $74.848, 80% of initial level
|
| Strike date: | March 22
|
| Pricing date: | March 25
|
| Settlement date: | March 28
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 0.4%
|
| Cusip: | 48134XLK9
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
